Back to Journals » Clinical Interventions in Aging » Volume 8
Polypharmacy in the HIV-infected older adult population
Authors Gleason L, Luque, Shah K
Received 3 April 2013
Accepted for publication 27 April 2013
Published 21 June 2013 Volume 2013:8 Pages 749—763
DOI https://doi.org/10.2147/CIA.S37738
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Lauren J Gleason1, Amneris E Luque2, Krupa Shah1
1Division of Geriatrics and Aging, Highland Hospital, Rochester, NY, USA; 2Division of Infectious Disease, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA
Abstract: The prevalence of human immunodeficiency virus (HIV) infection among people older than 50 years is increasing. Older HIV-infected patients are particularly at risk for polypharmacy because they often have multiple comorbidities that require pharmacotherapy. Overall, there is not much known with respect to both the impact of aging on medication use in HIV-infected individuals, and the potential for interactions with highly active antiretroviral therapy (HAART) and coadministered medications and its clinical consequences. In this review, we aim to provide an overview of polypharmacy with a focus on its impact on the HIV-infected older adult population and to also provide some clinical considerations in this high-risk population.
Keywords: HIV, older adults, polypharmacy
© 2013 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.